reference/32454563

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32454563

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Meta-Analysis\|Systematic Review
endingPage	765
issn	2215-0366
issueIdentifier	9
pageRange	753-765
publicationName	The lancet. Psychiatry
startingPage	753
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1d03dd466ae98ca23525c6858ac94d46 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c1b9f1c2d5cc1361ccf28b0108bd7179 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2bddc24efc1cb4981f2f472fe835cc41 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6e0abc599b7a8e7878c33858711f1b04 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_12dc3632b59fad5db2ab7c79fa76eb9e
bibliographicCitation	Schneider-Thoma J, Efthimiou O, Bighelli I, Dörries C, Huhn M, Krause M, Reichelt L, Röder H, Furukawa TA, Davis JM, Leucht S. Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis. Lancet Psychiatry. 2019 Sep;6(9):753–65. doi: 10.1016/s2215-0366(19)30223-8. PMID: 31320283.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95a876d55cb67e7c136cd1ff223b8b2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_559e78330c3b20636a5a46cf09e2da83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac96f00cd5fad1fab3a9b3666b6b9a8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37fc5eee3ab39b6a0d208004d48db033 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4093b8e68c8c26360631d256172a54ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af2a1605a8bd8c4ac7c3e530279165c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64b7b4852767c851ef32cd972b62f472 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4011-1189 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79483e22d370b66d99fa3d8c2bea2d46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4af7f9c498cd279cfe4024bcb197bb7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b2e6e340e6929ba06c2cf5d10c8834 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ccb8535c42b47b1a71e6d9636a8f0b2
date	201909
identifier	https://pubmed.ncbi.nlm.nih.gov/31320283 https://doi.org/10.1016/s2215-0366%2819%2930223-8
isPartOf	https://portal.issn.org/resource/ISSN/2215-0366 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42935
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis
discusses	http://id.nlm.nih.gov/mesh/M0021770 http://id.nlm.nih.gov/mesh/M0016932
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001523Q000188 http://id.nlm.nih.gov/mesh/D020886Q000139 http://id.nlm.nih.gov/mesh/D010919Q000009 http://id.nlm.nih.gov/mesh/D014150Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D020886Q000401 http://id.nlm.nih.gov/mesh/D001523Q000401 http://id.nlm.nih.gov/mesh/D010919Q000008 http://id.nlm.nih.gov/mesh/D002681Q000453 http://id.nlm.nih.gov/mesh/D014150Q000145 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D020886Q000453 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D015994 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D014150Q000627 http://id.nlm.nih.gov/mesh/D006801

Showing number of triples: 1 to 56 of 56.